Survival Time After RS and hfSRT of Brain Metastases


Gunnar Surber from the Center for Stereotactic Neurosurgery and Radiosurgery at HELIO Clinic in Erfurt, Germany, discusses survival time after the interdisciplinary treatment of brain metastases with radiosurgery and hypofractionated stereotactic radiotherapy. He begins by giving an overview of their treated patient population as well as the treatment strategies employed at his institution for brain mets. He then delves into the prognostic relevant factors and gives a comparison of radiosurgery versus hypofractionated stereotactic radiotherapy including their effects before outlining case reports of specific patients.

About the speaker

Gunnar Surber

Gunnar Surber
Helios Klinikum Erfurt, Germany


Related Videos

  • Control of Brain Metastases in the Eloquent Brain using SRS

    Control of Brain Metastases in the Eloquent Brain using SRS

  • Brainlab Elements Multiple Brain Mets SRS 2.0のコミッショニングと品質管理

    Brainlab Elements Multiple Brain Mets SRS 2.0のコミッショニングと品質管理

    宮部　結城　先生 / Yuuki Miyabe, Physicist
    京都大学医学部附属病院
    Show video

  • First Clinical Applications of ExacTrac Dynamic

    First Clinical Applications of ExacTrac Dynamic

    Thierry Gevaert, PhD
    Universitair Ziekenhuis Brussel
    Show video

  • Expert Demo Session: Elements Multiple Brain Mets SRS 3.0

    Expert Demo Session: Elements Multiple Brain Mets SRS 3.0

    Nzhde Agazaryan, PhD
    University of California Los Angeles, USA
    Show video

  • 静岡がんセンターにおける転移性脳腫瘍の治療戦略の変遷 / History of Treatment Strategy against Brain Metastases at Shizuoka Cancer Center

    静岡がんセンターにおける転移性脳腫瘍の治療戦略の変遷 / History of Treatment Strategy against Brain Metastases at Shizuoka Cancer Center

    原田　英幸　先生 / Hideyuki Harada, M.D., Ph.D.
    静岡県立静岡がんセンター / Shizuoka Cancer Center
    Show video

  • Brainlab Elements Multiple Brain Mets SRS 2.0の初期使用経験について

    Brainlab Elements Multiple Brain Mets SRS 2.0の初期使用経験について

    宇藤　恵　先生 / Megumi Uto, M.D., Ph.D.
    京都大学大学院医学研究科 / Kyoto University
    Show video

  • Contrast Clearance Analysis for Differentiating Tumor from Treatment Effects

    Contrast Clearance Analysis for Differentiating Tumor from Treatment Effects

    Dheerendra Prasad, MD
    Roswell Park Comprehensive Cancer Center
    Show video

  • Impact of Margins for Single Isocenter Multiple Target Treatments

    Impact of Margins for Single Isocenter Multiple Target Treatments

    Nzhde Agazaryan, PhD
    University of California Los Angeles, USA
    Show video


Back

Interested in watching this clinical talk? Please click on the button “WATCH Video” to enter your contact details and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Video related updates.

WATCH Video

Keep Watching

Thank you for watching! Please enter your contact details below to continue watching and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Circle video related updates.

  • Please read the following notice
    I have read the privacy policy. I agree that my information and data will be collected and stored electronically in order to answer my enquiry. Please note: You can revoke your consent at any time with effect for the future by emailing legal@brainlab.com.

Watch video No Thanks

Already Novalis Circle Member?

Member Login

Register now

Thank you for your interest in our Novalis Circle videos. Full-access to the media library is currently available for Novalis Radiosurgery users only. If you are a customer, please register or login to continue.

Register Now Login